Reports
Sale
Global Neurothrombectomy Devices Market Share, Growth, Trends, Forecast: By Product Type: Clot Retrieval Devices, Aspiration Devices, Vascular Snares, Others; By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Others; Regional Analysis; Patent Analysis; Grants Analysis; Funding Analysis; Supplier Landscape; 2024-2032
Global Neurothrombectomy Devices Market Outlook
The global neurothrombectomy devices market was valued at USD 703.14 million in 2023 and is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 as a result of the increasing number of incidences of acute ischemic stroke.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Neurothrombectomy devices are used in cerebral neurovasculature to retrieve blood clotting. It reduces the patient mortality rate.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The neurothrombectomy devices market can be broadly categorized based on:
- End-Use
- Hospitals
- Ambulatory Surgical Centres
- Emergency Clinics
- Others
- Product Type
- Vascular Snares
- Clot Retrievers
- Aspiration/Suction Devices
The EMR report looks into the regional markets of neurothrombectomy devices like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market Analysis
The global neurothrombectomy devices market is being driven by the rising unhealthy lifestyle of individuals, along with the growing awareness about diseases. The other factors leading to the growth of the industry are technological advancements, rising population consciousness, and increasing rate of acute ischemic strokes.
Europe is the largest market shareholder in the industry due to the rising number of patients suffering from acute ischemic stroke, increasing endorsements for neurothrombectomy devices, and the launch of new products by companies. North America is expected to grow significantly in the forecast period as a result of technological advancements, increasing cases of ischemic stroke, and the growing demand for insignificantly intrusive surgeries.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global neurothrombectomy devices market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Medtronic (NYSE: MDT)
- iPhenox Gmbh
- Acandis Gmbh
- Vesalio
- Penumbra, Inc
- Stryker Corporation
- Others
The EMR report gives an in-depth insight into the neurothrombectomy devices market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neurothrombectomy Devices Market Overview
3.1 Global Neurothrombectomy Devices Market Historical Value (2017-2023)
3.2 Global Neurothrombectomy Devices Market Forecast Value (2024-2032)
4 Global Neurothrombectomy Devices Market Landscape
4.1 Global Neurothrombectomy Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neurothrombectomy Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global Neurothrombectomy Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neurothrombectomy Devices Market Segmentation
6.1 Global Neurothrombectomy Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Clot Retrieval Devices
6.1.3 Aspiration Devices
6.1.4 Vascular Snares
6.1.5 Others
6.2 Global Neurothrombectomy Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Global Neurothrombectomy Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Neurothrombectomy Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Neurothrombectomy Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Neurothrombectomy Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Neurothrombectomy Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Neurothrombectomy Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Acandis GmbH
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Stryker
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Phenox GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Terumo Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 W.L. Gore & Associatess, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Vesalio, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Teleflex Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Edwards Lifesciences Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ARGON MEDICAL
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Koninklijke Philips N.V.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Microport Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Johnson & Johnson Private Limited
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Neurothrombectomy Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global neurothrombectomy devices market attained a value of nearly USD 703.14 million.
The market is projected to grow at a CAGR of 5.5% between 2024 and 2032.
The major drivers of the industry such as unhealthy lifestyle, growing health awareness, growing investment in the medical sector, and demand for minimally invasive surgeries are expected to aid the market growth.
Growing technological advancements and the increasing number of incidences of acute ischemic stroke are the key market trends guiding the growth of the market.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with Europe accounting for the largest share in the market.
Vascular snares, clot retrievers, and aspiration/suction devices are the major product types in the industry.
The significant end-use segments of the product include hospitals, ambulatory surgical centres, and emergency clinics, among others.
The major players in the industry are Medtronic Plc, iPhenox GmbH, Acandis GmbH, Vesalio LLC, Penumbra, Inc., and Stryker Corporation, among others.
Analyst Review
The global neurothrombectomy devices market attained a value of USD 703.14 million in 2023 driven by the growing prevalence of acute ischemic stroke. Aided by the growing health awareness and growing investment in the medical sector, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5.5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product types, the industry can be segmented into vascular snares, clot retrievers, and aspiration/suction devices. On the basis of end-use, the industry can be categorised into hospitals, ambulatory surgical centres, and emergency clinics, among others. The major regional markets for neurothrombectomy devices are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with Europe accounting for the largest share of the market. The key players in the above market include Medtronic Plc, iPhenox GmbH, Acandis GmbH, Vesalio LLC, Penumbra, Inc., and Stryker Corporation, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER